Agilent Technologies, Inc. – NYSE:A
Agilent Technologies stock price today
$120.11
-15.42
-11.38%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 1 hour
Agilent Technologies stock price monthly change
+2.50%
month
Agilent Technologies stock price quarterly change
+2.50%
quarter
Agilent Technologies stock price yearly change
-3.06%
year
Agilent Technologies key metrics
Market Cap | 38.36B |
Enterprise value | 40.77B |
P/E | 30.25 |
EV/Sales | 6.26 |
EV/EBITDA | 23.52 |
Price/Sales | 5.94 |
Price/Book | 6.61 |
PEG ratio | 2.17 |
EPS | 4.25 |
Revenue | 6.59B |
EBITDA | 1.61B |
Income | 1.24B |
Revenue Q/Q | -8.38% |
Revenue Y/Y | -6.37% |
Profit margin | 19.8% |
Oper. margin | 23.1% |
Gross margin | 54.38% |
EBIT margin | 23.1% |
EBITDA margin | 24.56% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAgilent Technologies stock price history
Agilent Technologies stock forecast
Agilent Technologies financial statements
Average Price Target
$150.5
Potential upside: 25.30%
Analysts Price target
Financials & Ratios estimates
| Jul 2023 | 1.67B | 111M | 6.64% |
|---|---|---|---|
| Oct 2023 | 1.68B | 475M | 28.14% |
| Jan 2024 | 1.65B | 348M | 20.99% |
| Apr 2024 | 1.57B | 308M | 19.58% |
0.52%
Yield TTM
| Payout ratio | 21.26% |
|---|
| 2020 | 0.7% |
|---|---|
| 2021 | 0.49% |
| 2022 | 0.6% |
| 2023 | 0.87% |
| 2024 | 0.73% |
| Jul 2023 | 10675000000 | 5.11B | 47.93% |
|---|---|---|---|
| Oct 2023 | 10763000000 | 4.91B | 45.69% |
| Jan 2024 | 10948000000 | 4.76B | 43.48% |
| Apr 2024 | 10856000000 | 4.64B | 42.76% |
| Jul 2023 | 562M | -89M | -322M |
|---|---|---|---|
| Oct 2023 | 516M | -40M | -201M |
| Jan 2024 | 485M | -95M | -240M |
| Apr 2024 | 333M | -109M | -291M |
Agilent Technologies alternative data
Agilent Technologies Social Media Accounts
What are followers?
+3.65%
month
| May 2025 | 21933 |
|---|---|
| Jul 2025 | 24077 |
| Aug 2025 | 24956 |
Agilent
| 25 Aug 2024 | 81 |
|---|---|
| 1 Sep 2024 | 75 |
| 8 Sep 2024 | 79 |
| 15 Sep 2024 | 77 |
| 22 Sep 2024 | 79 |
| 29 Sep 2024 | 79 |
| 6 Oct 2024 | 74 |
| 13 Oct 2024 | 79 |
| 20 Oct 2024 | 72 |
| 27 Oct 2024 | 68 |
| 3 Nov 2024 | 70 |
| 10 Nov 2024 | 65 |
| 17 Nov 2024 | 73 |
| 24 Nov 2024 | 72 |
| 1 Dec 2024 | 66 |
| 8 Dec 2024 | 72 |
| 15 Dec 2024 | 71 |
| 22 Dec 2024 | 68 |
| 29 Dec 2024 | 42 |
| 5 Jan 2025 | 31 |
Agilent Technologies
| 4 Aug 2024 | 84 |
|---|---|
| 11 Aug 2024 | 68 |
| 18 Aug 2024 | 78 |
| 25 Aug 2024 | 66 |
| 1 Sep 2024 | 68 |
| 8 Sep 2024 | 65 |
| 15 Sep 2024 | 66 |
| 22 Sep 2024 | 67 |
| 29 Sep 2024 | 57 |
| 6 Oct 2024 | 57 |
| 13 Oct 2024 | 58 |
| 20 Oct 2024 | 54 |
| 27 Oct 2024 | 63 |
| 3 Nov 2024 | 71 |
| 10 Nov 2024 | 71 |
| 17 Nov 2024 | 64 |
| 24 Nov 2024 | 63 |
| 1 Dec 2024 | 69 |
| 8 Dec 2024 | 47 |
| 15 Dec 2024 | 41 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
What is job openings count?
| Sep 2023 | 238 |
|---|---|
| Oct 2023 | 191 |
| Nov 2023 | 282 |
| Dec 2023 | 214 |
| Jan 2024 | 166 |
| Feb 2024 | 247 |
| Apr 2024 | 392 |
| May 2024 | 383 |
| Jun 2024 | 722 |
| Jul 2024 | 589 |
| Sep 2023 | 18,000 |
|---|---|
| Oct 2023 | 18,300 |
| Nov 2023 | 18,300 |
| Dec 2023 | 18,000 |
| Jan 2024 | 18,100 |
| Feb 2024 | 18,100 |
| Mar 2024 | 17,700 |
| Apr 2024 | 17,700 |
| May 2024 | 17,700 |
| Jun 2024 | 18,000 |
| Jul 2024 | 17,600 |
Agilent Technologies other data
84.90%
-0.47%
of A is owned by hedge funds
898
-59
257.25M
-4.84M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2023 | 0 | 95929 |
| Mar 2024 | 0 | 61610 |
| Jun 2024 | 0 | 18916 |
| Jul 2024 | 0 | 1958 |
| Aug 2024 | 0 | 1958 |
| Sep 2024 | 0 | 15047 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | MCDONNELL PADRAIG director, officer: President an.. | Common Stock | 47 | $150 | $7,050 | ||
Sale | GRAU DOMINIQUE officer: Senior Vice President | Common Stock | 5,010 | $145 | $726,450 | ||
Sale | GRAU DOMINIQUE officer: Senior Vice President | Common Stock | 9,990 | $145 | $1,448,550 | ||
Sale | MCDONNELL PADRAIG director, officer: President an.. | Common Stock | 1,958 | $145 | $283,910 | ||
Sale | MCDONNELL PADRAIG director, officer: President an.. | Common Stock | 1,958 | $140 | $274,120 | ||
Sale | MCDONNELL PADRAIG director, officer: President an.. | Common Stock | 1,958 | $135 | $264,330 | ||
Sale | GRAU DOMINIQUE officer: Senior Vice President | Common Stock | 15,000 | $133.28 | $1,999,260 | ||
Sale | MCDONNELL PADRAIG director, officer: President an.. | Common Stock | 1,958 | $130 | $254,540 | ||
Sale | BINNS PHILIP officer: Senior Vice President | Common Stock | 2,827 | $147.54 | $417,096 | ||
Sale | MCMULLEN MICHAEL R. director, officer.. | Common Stock | 52,297 | $150 | $7,844,550 |
| Patent |
|---|
Grant Filling date: 23 Nov 2020 Issue date: 13 Sep 2022 |
Grant Filling date: 8 Nov 2019 Issue date: 13 Sep 2022 |
Grant Filling date: 13 Jun 2018 Issue date: 13 Sep 2022 |
Application Filling date: 26 May 2022 Issue date: 8 Sep 2022 |
Application Filling date: 30 Jul 2020 Issue date: 8 Sep 2022 |
Application Filling date: 22 Jul 2020 Issue date: 8 Sep 2022 |
Grant Utility: Unions and couplers Filling date: 28 Feb 2020 Issue date: 6 Sep 2022 |
Application Filling date: 20 May 2022 Issue date: 1 Sep 2022 |
Application HYDROCINNAMOYL PROTECTED RIBOGUANOSINE PHOSPHORAMIDITES FOR DECREASING DEPYRIMIDINATION FROM ALKYL AMINE EXPOSURE DURING FINAL DEPROTECTION Filling date: 26 Feb 2022 Issue date: 1 Sep 2022 |
Application Filling date: 24 Feb 2022 Issue date: 1 Sep 2022 |
| Quarter | Transcript |
|---|---|
| Q2 2024 29 May 2024 | Q2 2024 Earnings Call Transcript |
| Q1 2024 27 Feb 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 20 Nov 2023 | Q4 2023 Earnings Call Transcript |
| Q3 2023 15 Aug 2023 | Q3 2023 Earnings Call Transcript |
Keysight Technologies: Remaining In My Sight, Despite Tougher Times
U.S. Wide-Moat Stocks On Sale - The April 2024 Heat Map
908 Devices: Rare Early-Stage Bioprocess Investment Opportunity
Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence
U.S. Wide-Moat Stocks On Sale - The February 2024 Heat Map
Horiba: Wonderful Japanese Company At A Very Attractive Price
U.S. Wide-Moat Stocks On Sale - The January 2024 Heat Map
Agilent Technologies Hit A Homerun
GE HealthCare Technologies Remains Ridiculously Undervalued
-
What's the price of Agilent Technologies stock today?
One share of Agilent Technologies stock can currently be purchased for approximately $120.11.
-
When is Agilent Technologies's next earnings date?
Unfortunately, Agilent Technologies's (A) next earnings date is currently unknown.
-
Does Agilent Technologies pay dividends?
Yes, Agilent Technologies pays dividends and its trailing 12-month yield is 0.52% with 21% payout ratio. The last Agilent Technologies stock dividend of $0.21 was paid on 26 Jan 2022.
-
How much money does Agilent Technologies make?
Agilent Technologies has a market capitalization of 38.36B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 4.73% to 6.51B US dollars.
-
What is Agilent Technologies's stock symbol?
Agilent Technologies, Inc. is traded on the NYSE under the ticker symbol "A".
-
What is Agilent Technologies's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Agilent Technologies?
Shares of Agilent Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Agilent Technologies's key executives?
Agilent Technologies's management team includes the following people:
- Mr. Michael R. McMullen Chief Executive Officer, Pres & Director(age: 64, pay: $2,420,000)
- Mr. Robert W. McMahon Senior Vice President & Chief Financial Officer(age: 56, pay: $1,050,000)
- Mr. Jacob Thaysen Senior Vice President and Pres of Life Sciences & Applied Markets Group(age: 50, pay: $956,320)
- Mr. Michael Tang Senior Vice President, Gen. Counsel & Sec.(age: 51, pay: $871,020)
- Mr. Samraat S. Raha Senior Vice President and Pres of Diagnostics & Genomics Group(age: 52, pay: $797,780)
-
How many employees does Agilent Technologies have?
As Jul 2024, Agilent Technologies employs 17,600 workers, which is 2% less then previous month and 1% less then previous quarter.
-
When Agilent Technologies went public?
Agilent Technologies, Inc. is publicly traded company for more then 25 years since IPO on 18 Nov 1999.
-
What is Agilent Technologies's official website?
The official website for Agilent Technologies is agilent.com.
-
Where are Agilent Technologies's headquarters?
Agilent Technologies is headquartered at 5301 Stevens Creek Boulevard, Santa Clara, CA.
-
How can i contact Agilent Technologies?
Agilent Technologies's mailing address is 5301 Stevens Creek Boulevard, Santa Clara, CA and company can be reached via phone at +800 2279770.
-
What is Agilent Technologies stock forecast & price target?
Based on 4 Wall Street analysts` predicted price targets for Agilent Technologies in the last 12 months, the avarage price target is $150.5. The average price target represents a 25.30% change from the last price of $120.11.
Agilent Technologies company profile:
Agilent Technologies, Inc.
agilent.comExchange:
NYSE
Full time employees:
17,400
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
5301 Stevens Creek Boulevard
Santa Clara, CA 95051
Santa Clara, CA 95051
CIK: 0001090872
ISIN: US00846U1016
CUSIP: 00846U101
